These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

182 related articles for article (PubMed ID: 11940408)

  • 1. [Immunophilins: neuroprotective agents and promoters of neural regeneration].
    Udina E; Navarro X
    Neurologia; 2002 Apr; 17(4):200-13. PubMed ID: 11940408
    [TBL] [Abstract][Full Text] [Related]  

  • 2. FK506 and the role of immunophilins in nerve regeneration.
    Gold BG
    Mol Neurobiol; 1997 Dec; 15(3):285-306. PubMed ID: 9457703
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Neuroimmunophilin ligands: evaluation of their therapeutic potential for the treatment of neurological disorders.
    Gold BG
    Expert Opin Investig Drugs; 2000 Oct; 9(10):2331-42. PubMed ID: 11060810
    [TBL] [Abstract][Full Text] [Related]  

  • 4. FKBP family proteins: immunophilins with versatile biological functions.
    Kang CB; Hong Y; Dhe-Paganon S; Yoon HS
    Neurosignals; 2008; 16(4):318-25. PubMed ID: 18635947
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Neuroimmunophilin ligands exert neuroregeneration and neuroprotection in midbrain dopaminergic neurons.
    Guo X; Dawson VL; Dawson TM
    Eur J Neurosci; 2001 May; 13(9):1683-93. PubMed ID: 11359520
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Neural roles of immunophilins and their ligands.
    Sabatini DM; Lai MM; Snyder SH
    Mol Neurobiol; 1997 Oct; 15(2):223-39. PubMed ID: 9396011
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Immunophilins: beyond immunosuppression.
    Hamilton GS; Steiner JP
    J Med Chem; 1998 Dec; 41(26):5119-43. PubMed ID: 9857082
    [No Abstract]   [Full Text] [Related]  

  • 8. [Immunosuppressive drugs and calcineurin].
    Masugi T; Otsuka K
    Tanpakushitsu Kakusan Koso; 1998 Sep; 43(12 Suppl):1739-43. PubMed ID: 9788176
    [No Abstract]   [Full Text] [Related]  

  • 9. [Interaction of immunophilin FKBP and intracellular Ca2+ release channels].
    Onoe H; Itonaga Y; Ito Y
    Fukuoka Igaku Zasshi; 2001 Jul; 92(7):272-7. PubMed ID: 11681278
    [No Abstract]   [Full Text] [Related]  

  • 10. FK506 and a nonimmunosuppressant derivative reduce axonal and myelin damage in experimental autoimmune encephalomyelitis: neuroimmunophilin ligand-mediated neuroprotection in a model of multiple sclerosis.
    Gold BG; Voda J; Yu X; McKeon G; Bourdette DN
    J Neurosci Res; 2004 Aug; 77(3):367-77. PubMed ID: 15248293
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Strain-specific differences in the effects of cyclosporin A and FK506 on the survival and regeneration of axotomized retinal ganglion cells in adult rats.
    Cui Q; Hodgetts SI; Hu Y; Luo JM; Harvey AR
    Neuroscience; 2007 May; 146(3):986-99. PubMed ID: 17408862
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Calcineurin-independent inhibition of the delayed rectifier K+ current by the immunosuppressant FK506 in rat hippocampal neurons.
    Yu Y; Chen XQ; Cui YY; Hu GY
    Brain Res; 2007 May; 1148():62-8. PubMed ID: 17355875
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Neuroimmunophilins: novel neuroprotective and neuroregenerative targets.
    Guo X; Dillman JF; Dawson VL; Dawson TM
    Ann Neurol; 2001 Jul; 50(1):6-16. PubMed ID: 11456311
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Immunophilin-loaded erythrocytes as a new delivery strategy for immunosuppressive drugs.
    Biagiotti S; Rossi L; Bianchi M; Giacomini E; Pierigè F; Serafini G; Conaldi PG; Magnani M
    J Control Release; 2011 Sep; 154(3):306-13. PubMed ID: 21640771
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Immunophilin ligands: from immunosuppressants to neuroprotective drugs].
    Tanaka K; Ogawa N
    Nihon Shinkei Seishin Yakurigaku Zasshi; 2004 Apr; 24(2):71-4. PubMed ID: 15164613
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Neuroimmunophilin ligands: the development of novel neuroregenerative/ neuroprotective compounds.
    Gold BG; Villafranca JE
    Curr Top Med Chem; 2003; 3(12):1368-75. PubMed ID: 12871168
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Calcineurin and cyclophilin D are differential targets of neuroprotection by immunosuppressants CsA and FK506 in ischemic brain damage.
    Uchino H; Ishii N; Shibasaki F
    Acta Neurochir Suppl; 2003; 86():105-11. PubMed ID: 14753416
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Neuroregenerative and neuroprotective actions of neuroimmunophilin compounds in traumatic and inflammatory neuropathies.
    Gold BG; Udina E; Bourdette D; Navarro X
    Neurol Res; 2004 Jun; 26(4):371-80. PubMed ID: 15198862
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Immunosuppressants: neuroprotection and promoting neurological recovery following peripheral nerve and spinal cord lesions.
    Sosa I; Reyes O; Kuffler DP
    Exp Neurol; 2005 Sep; 195(1):7-15. PubMed ID: 15935348
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Drug target validation and identification of secondary drug target effects using DNA microarrays.
    Marton MJ; DeRisi JL; Bennett HA; Iyer VR; Meyer MR; Roberts CJ; Stoughton R; Burchard J; Slade D; Dai H; Bassett DE; Hartwell LH; Brown PO; Friend SH
    Nat Med; 1998 Nov; 4(11):1293-301. PubMed ID: 9809554
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.